These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 22702392)
1. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease. Noristani HN; Verkhratsky A; Rodríguez JJ Aging Cell; 2012 Oct; 11(5):810-22. PubMed ID: 22702392 [TBL] [Abstract][Full Text] [Related]
2. Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease. Noristani HN; Olabarria M; Verkhratsky A; Rodríguez JJ Eur J Neurosci; 2010 Jul; 32(1):71-9. PubMed ID: 20576032 [TBL] [Abstract][Full Text] [Related]
3. AβPP accumulation and/or intraneuronal amyloid-β accumulation? The 3xTg-AD mouse model revisited. Wirths O; Dins A; Bayer TA J Alzheimers Dis; 2012; 28(4):897-904. PubMed ID: 22112547 [TBL] [Abstract][Full Text] [Related]
4. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice. Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754 [TBL] [Abstract][Full Text] [Related]
5. Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study. Noristani HN; Meadows RS; Olabarria M; Verkhratsky A; Rodríguez JJ Cell Death Dis; 2011 Sep; 2(9):e210. PubMed ID: 21918544 [TBL] [Abstract][Full Text] [Related]
6. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
7. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597 [TBL] [Abstract][Full Text] [Related]
9. Increased densities of resting and activated microglia in the dentate gyrus follow senile plaque formation in the CA1 subfield of the hippocampus in the triple transgenic model of Alzheimer's disease. Rodríguez JJ; Noristani HN; Hilditch T; Olabarria M; Yeh CY; Witton J; Verkhratsky A Neurosci Lett; 2013 Sep; 552():129-34. PubMed ID: 23827221 [TBL] [Abstract][Full Text] [Related]
10. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
11. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology. Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549 [TBL] [Abstract][Full Text] [Related]
12. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994 [TBL] [Abstract][Full Text] [Related]
15. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease. Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395 [TBL] [Abstract][Full Text] [Related]
16. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease. Jawhar S; Trawicka A; Jenneckens C; Bayer TA; Wirths O Neurobiol Aging; 2012 Jan; 33(1):196.e29-40. PubMed ID: 20619937 [TBL] [Abstract][Full Text] [Related]
17. Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice. Shie FS; LeBoeuf RC; Jin LW Neuroreport; 2003 Jan; 14(1):123-9. PubMed ID: 12544843 [TBL] [Abstract][Full Text] [Related]
18. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]
19. Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology? Bayer TA; Wirths O Biochem Soc Trans; 2011 Aug; 39(4):857-61. PubMed ID: 21787313 [TBL] [Abstract][Full Text] [Related]
20. Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer's disease. Kumar S; Wirths O; Theil S; Gerth J; Bayer TA; Walter J Acta Neuropathol; 2013 May; 125(5):699-709. PubMed ID: 23525537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]